annual cash & cash equivalents:
$3.01B-$17.00M(-0.56%)Summary
- As of today (September 12, 2025), CME annual cash & cash equivalents is $3.01 billion, with the most recent change of -$17.00 million (-0.56%) on December 31, 2024.
- During the last 3 years, CME annual cash & cash equivalents has risen by +$57.20 million (+1.94%).
- CME annual cash & cash equivalents is now -22.98% below its all-time high of $3.91 billion, reached on December 31, 2007.
Performance
CME Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.11B+$579.90M(+38.01%)Summary
- As of today (September 12, 2025), CME quarterly cash & cash equivalents is $2.11 billion, with the most recent change of +$579.90 million (+38.01%) on June 30, 2025.
- Over the past year, CME quarterly cash & cash equivalents has increased by +$188.60 million (+9.84%).
- CME quarterly cash & cash equivalents is now -46.16% below its all-time high of $3.91 billion, reached on December 31, 2007.
Performance
CME quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CME Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.6% | +9.8% |
| 3 y3 years | +1.9% | +6.4% |
| 5 y5 years | +83.8% | +40.6% |
CME Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.6% | +6.8% | -30.5% | +38.0% |
| 5 y | 5-year | -0.6% | +83.8% | -30.5% | +101.3% |
| alltime | all time | -23.0% | +3916.9% | -46.2% | +2946.8% |
CME Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.11B(+38.0%) |
| Mar 2025 | - | $1.53B(-49.4%) |
| Dec 2024 | $3.01B(-0.6%) | $3.01B(+23.4%) |
| Sep 2024 | - | $2.44B(+27.3%) |
| Jun 2024 | - | $1.92B(+22.6%) |
| Mar 2024 | - | $1.56B(-48.4%) |
| Dec 2023 | $3.03B(+7.4%) | $3.03B(+25.7%) |
| Sep 2023 | - | $2.41B(+21.0%) |
| Jun 2023 | - | $1.99B(+18.9%) |
| Mar 2023 | - | $1.68B(-40.6%) |
| Dec 2022 | $2.82B(-4.5%) | $2.82B(+26.7%) |
| Sep 2022 | - | $2.23B(+12.5%) |
| Jun 2022 | - | $1.98B(-8.4%) |
| Mar 2022 | - | $2.16B(-26.9%) |
| Dec 2021 | $2.95B(+69.9%) | $2.95B(+87.7%) |
| Sep 2021 | - | $1.57B(+31.6%) |
| Jun 2021 | - | $1.20B(+14.4%) |
| Mar 2021 | - | $1.05B(-39.8%) |
| Dec 2020 | $1.74B(+6.1%) | $1.74B(+21.7%) |
| Sep 2020 | - | $1.43B(-4.6%) |
| Jun 2020 | - | $1.50B(+60.5%) |
| Mar 2020 | - | $933.50M(-43.0%) |
| Dec 2019 | $1.64B(+13.1%) | $1.64B(+26.5%) |
| Sep 2019 | - | $1.30B(+26.5%) |
| Jun 2019 | - | $1.02B(-5.3%) |
| Mar 2019 | - | $1.08B(-25.4%) |
| Dec 2018 | $1.45B(-27.3%) | $1.45B(-53.4%) |
| Sep 2018 | - | $3.11B(+10.5%) |
| Jun 2018 | - | $2.82B(+105.9%) |
| Mar 2018 | - | $1.37B(-31.4%) |
| Dec 2017 | $1.99B(+0.6%) | $1.99B(+12.7%) |
| Sep 2017 | - | $1.77B(+19.8%) |
| Jun 2017 | - | $1.48B(+5.1%) |
| Mar 2017 | - | $1.40B(-29.1%) |
| Dec 2016 | $1.98B(+10.3%) | $1.98B(+29.3%) |
| Sep 2016 | - | $1.53B(+20.6%) |
| Jun 2016 | - | $1.27B(+1.1%) |
| Mar 2016 | - | $1.26B(-30.0%) |
| Dec 2015 | $1.80B(+21.6%) | $1.80B(+16.8%) |
| Sep 2015 | - | $1.54B(+22.2%) |
| Jun 2015 | - | $1.26B(-30.3%) |
| Mar 2015 | - | $1.81B(+22.2%) |
| Dec 2014 | $1.48B(-42.7%) | $1.48B(+23.4%) |
| Sep 2014 | - | $1.20B(+4.4%) |
| Jun 2014 | - | $1.15B(-1.4%) |
| Mar 2014 | - | $1.16B(-54.9%) |
| Dec 2013 | $2.58B | $2.58B(+18.8%) |
| Sep 2013 | - | $2.17B(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $2.07B(+6.4%) |
| Mar 2013 | - | $1.94B(+14.3%) |
| Dec 2012 | $1.70B(+50.6%) | $1.70B(-19.7%) |
| Sep 2012 | - | $2.12B(+54.0%) |
| Jun 2012 | - | $1.38B(+24.3%) |
| Mar 2012 | - | $1.11B(-2.0%) |
| Dec 2011 | $1.13B(+24.8%) | $1.13B(+23.4%) |
| Sep 2011 | - | $915.90M(+16.1%) |
| Jun 2011 | - | $788.60M(+3.9%) |
| Mar 2011 | - | $759.30M(-16.1%) |
| Dec 2010 | $905.40M(+198.6%) | $905.40M(+47.8%) |
| Sep 2010 | - | $612.50M(+49.9%) |
| Jun 2010 | - | $408.60M(-16.7%) |
| Mar 2010 | - | $490.50M(+61.8%) |
| Dec 2009 | $303.20M(-70.7%) | $303.20M(+1.8%) |
| Sep 2009 | - | $297.80M(-46.3%) |
| Jun 2009 | - | $554.10M(-25.4%) |
| Mar 2009 | - | $743.10M(-28.2%) |
| Dec 2008 | $1.03B(-73.5%) | $1.03B(-36.1%) |
| Sep 2008 | - | $1.62B(+34.2%) |
| Jun 2008 | - | $1.21B(-1.3%) |
| Mar 2008 | - | $1.22B(-68.8%) |
| Dec 2007 | $3.91B(+16.7%) | $3.91B(+13.6%) |
| Sep 2007 | - | $3.44B(-9.8%) |
| Jun 2007 | - | $3.81B(+9.9%) |
| Mar 2007 | - | $3.47B(+3.6%) |
| Dec 2006 | $3.35B(+9.3%) | $3.35B(+34.3%) |
| Sep 2006 | - | $2.49B(-1.2%) |
| Jun 2006 | - | $2.53B(-26.9%) |
| Mar 2006 | - | $3.45B(+12.7%) |
| Dec 2005 | $3.06B(+31.5%) | $3.06B(+45.2%) |
| Sep 2005 | - | $2.11B(-20.7%) |
| Jun 2005 | - | $2.66B(+8.7%) |
| Mar 2005 | - | $2.45B(+5.1%) |
| Dec 2004 | $2.33B(+28.3%) | $2.33B(-4.7%) |
| Sep 2004 | - | $2.44B(+72.8%) |
| Jun 2004 | - | $1.41B(-26.7%) |
| Mar 2004 | - | $1.93B(+6.2%) |
| Dec 2003 | $1.82B(+37.1%) | $1.82B(+16.4%) |
| Sep 2003 | - | $1.56B(+7.6%) |
| Jun 2003 | - | $1.45B(+306.4%) |
| Mar 2003 | - | $356.95M(-73.1%) |
| Dec 2002 | $1.32B(+27.0%) | $1.32B(+76.1%) |
| Sep 2002 | - | $752.13M(-24.7%) |
| Jun 2002 | - | $999.30M(+10.7%) |
| Mar 2002 | - | $902.98M(+1206.8%) |
| Dec 2001 | $1.04B(+1291.3%) | $69.10M |
| Dec 2000 | $74.98M | - |
FAQ
- What is CME Group Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CME Group Inc.?
- What is CME Group Inc. annual cash & cash equivalents year-on-year change?
- What is CME Group Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for CME Group Inc.?
- What is CME Group Inc. quarterly cash & cash equivalents year-on-year change?
What is CME Group Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of CME is $3.01B
What is the all time high annual cash & cash equivalents for CME Group Inc.?
CME Group Inc. all-time high annual cash & cash equivalents is $3.91B
What is CME Group Inc. annual cash & cash equivalents year-on-year change?
Over the past year, CME annual cash & cash equivalents has changed by -$17.00M (-0.56%)
What is CME Group Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CME is $2.11B
What is the all time high quarterly cash & cash equivalents for CME Group Inc.?
CME Group Inc. all-time high quarterly cash & cash equivalents is $3.91B
What is CME Group Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, CME quarterly cash & cash equivalents has changed by +$188.60M (+9.84%)